Hypertension Clinical Trial
To assess the risk of incident atrial fibrillation after stopping anti-hypertensive medication including beta-blockers and ACE inhibitors. Also, to assess the role of genetics in subsequent risk of stroke among patients with atrial fibrillation.
BACKGROUND:
Prevention and treatment of atrial fibrillation (AF) is a significant public health issue.
Atrial fibrillation affects 9 percent of persons aged 80 to 89. It is associated with
elevated risk of stroke and death. The condition is likely to increase as survival rates
from myocardial infarction continue to improve, prevalence of congestive heart failure
grows, and treatment approaches evolve. The study will assess the safety of commonly used
medications in relation to the risk of incident atrial fibrillation, and will assess the
association of several genetic polymorphisms with stroke risk after AF onset. Several lines
of evidence suggest that both beta-blockers and ACE inhibitors may prevent or inhibit the
atrial electrical remodeling that allows AF to become established and maintained. Withdrawal
of these medications may be associated with increased risk of AF in individuals at risk.
Genetic polymorphisms that promote thrombosis are associated with an increased risk of
venous thrombosis, and in some studies, with arterial thrombosis including stroke or
myocardial infarction. Although several recently published trials indicate that warfarin or
aspirin treatment of patients with AF decreases the risk of stroke, little is known about
the risk of stroke as a complication of AF in relation to genetic variants that affect
clotting.
DESIGN NARRATIVE:
The main tasks of the case-control study are: 1) identification of cases with incident AF
and controls; 2) review of outpatient and inpatient medical records to assess eligibility
and collect information on risk factors and medical history; 3) classification of medication
use over time; 4) for AF patients, telephone interview and collection of blood samples; 5)
blood specimen processing, DNA extraction, and genotyping; and 6) data analysis of the
associations of medication use and genotype with AF onset and stroke complications.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
| Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
| Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
| Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
| Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
| Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
| Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
| Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
| Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
| Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
| Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
| Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
| Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |